David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$453M |
| 2 |
Oracle
ORCL
|
+$431M |
| 3 |
Apple
AAPL
|
+$376M |
| 4 |
SLB Ltd
SLB
|
+$353M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$746M |
| 2 |
AET
Aetna Inc
AET
|
+$378M |
| 3 |
NVIDIA
NVDA
|
+$348M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$307M |
| 5 |
AT&T
T
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.42% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 11.33% |
| 4 | Financials | 7.58% |
| 5 | Communication Services | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
MetLife
MET
$60.9B
| $853K | ﹤0.01% |
20,769
+11,040
| +113% | +$474K |
|
2727
CALL
BioMarin Pharmaceuticals
BMRN
$12.8B
| $852K | ﹤0.01% |
10,000
| – | – |
|
2728
LSI Industries
LYTS
$758M
| $852K | ﹤0.01% |
268,754
+6,447
| +2% | +$26.9K |
|
|
CRC
2729
PUT
DELISTED
California Resources Corporation
CRC
| $852K | ﹤0.01% |
50,000
+20,000
| +67% | +$569K |
|
|
AMWD
2730
DELISTED
American Woodmark
AMWD
| $851K | ﹤0.01% |
+15,280
| New | +$974K |
|
|
WLL
2731
PUT
DELISTED
Whiting Petroleum Corporation
WLL
| $851K | ﹤0.01% |
+500
| New | +$1.28M |
|
2732
PUT
NOV
NOV
$7.11B
| $848K | ﹤0.01% |
+33,000
| New | +$1.14M |
|
2733
SandRidge Energy
SD
$515M
| $847K | ﹤0.01% |
111,257
+93,657
| +532% | +$906K |
|
|
PVG
2734
CALL
DELISTED
PRETIUM RESOURCES INC.
PVG
| $845K | ﹤0.01% |
100,000
| – | – |
|
2735
Vale
VALE
$65.2B
| $844K | ﹤0.01% |
63,998
-131,250
| -67% | -$1.88M |
|
|
HUD
2736
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $843K | ﹤0.01% |
49,182
+25,320
| +106% | +$498K |
|
2737
CALL
D.R. Horton
DHI
$42.2B
| $842K | ﹤0.01% |
24,300
-124,300
| -84% | -$4.53M |
|
2738
Century Aluminum
CENX
$4.38B
| $839K | ﹤0.01% |
114,729
-207,636
| -64% | -$1.88M |
|
|
PYX
2739
DELISTED
Pyxus International, Inc.
PYX
| $839K | ﹤0.01% |
70,778
+59,660
| +537% | +$1.25M |
|
|
CARB
2740
DELISTED
Carbonite Inc
CARB
| $839K | ﹤0.01% |
33,204
-56,344
| -63% | -$1.67M |
|
2741
CALL
Devon Energy
DVN
$51.6B
| $838K | ﹤0.01% |
37,200
-277,400
| -88% | -$8.52M |
|
2742
PUT
Adient
ADNT
$1.44B
| $837K | ﹤0.01% |
55,600
-93,900
| -63% | -$2.43M |
|
|
CCRN
2743
DELISTED
Cross Country Healthcare
CCRN
| $836K | ﹤0.01% |
114,119
+26,061
| +30% | +$218K |
|
2744
CALL
Puma Biotechnology
PBYI
$481M
| $834K | ﹤0.01% |
41,000
| – | – |
|
|
PVTL
2745
PUT
DELISTED
Pivotal Software, Inc.
PVTL
| $834K | ﹤0.01% |
+51,000
| New | +$912K |
|
|
CZZ
2746
DELISTED
Cosan Limited
CZZ
| $831K | ﹤0.01% |
94,376
-301,710
| -76% | -$2.43M |
|
2747
Artisan Partners
APAM
$3.1B
| $829K | ﹤0.01% |
+37,491
| New | +$1,000K |
|
|
DLPH
2748
CALL
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $829K | ﹤0.01% |
+57,900
| New | +$1.13M |
|
2749
CALL
Trip.com Group
TCOM
$29B
| $828K | ﹤0.01% |
30,600
-45,000
| -60% | -$1.37M |
|
2750
Xenon Pharmaceuticals
XENE
$5.85B
| $828K | ﹤0.01% |
+131,220
| New | +$1.17M |
|
Similar funds
David Shaw's Q4 2018 Portfolio in Review
As of Q4 2018, David Shaw held 4,217 positions worth $72.6B, down 13% from $83.2B the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.
David Shaw deployed $3.99B of net new capital in Q4 2018, opening 541 new positions and adding to 1,544 existing holdings. Its largest new stake was Alibaba: 3,066,336 shares worth $420M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $746M trimmed.
- David Shaw's largest Q4 2018 buy was Alibaba: 3,066,336 shares worth $420M.
- David Shaw added most to Oracle in Q4 2018, an estimated $431M increase.
- David Shaw's biggest Q4 2018 reduction was Amazon, cutting an estimated $746M.
- David Shaw fully exited Aetna Inc in Q4 2018, selling an estimated $378M.
- David Shaw's ten largest holdings make up 8.9% of its $72.6B portfolio in Q4 2018.
- David Shaw opened 541 new positions and closed 497 in Q4 2018.
- David Shaw's portfolio value fell 13% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.